geographic atrophy

Nanoscope Therapeutics Partners With McKesson for Retinal Therapy

DALLAS, May 27, 2026 Nanoscope Therapeutics Inc., a biotechnology company developing disease-agnostic therapies for retinal degeneration and vision impairment,...

By cGxPwire Editor
May 28, 2026

MedTech

Renerva Implants First PNM-CAP Device for Neuroma Pain

PITTSBURGH, May 13, 2026 Renerva, Inc. announced the successful first-in-human implantation of its investigational PNM-CAP™ device, marking a major...

By cGxPwire Editor
May 14, 2026

.Clinical

Astellas Reports IZERVAY Reduced Vision Decline in GA Patients

NORTHBROOK, Ill., May 12, 2026 Astellas Pharma US announced new clinical findings showing that IZERVAY® (avacincaptad pegol intravitreal solution)...

By cGxPwire Editor
May 14, 2026

.Clinical

Ocugen OCU410 Gene Therapy Cuts GA Progression

MALVERN, Pennsylvania, USA | March 24, 2026 In a major breakthrough for retinal disease treatment, Ocugen, Inc. has announced...

By cGxPwire Editor
March 25, 2026

.Clinical

PulseSight Completes Phase I Dosing of PST-611 in Dry AMD

Paris, France | January 22, 2026 — PulseSight Therapeutics, a Paris-based clinical-stage biotechnology company, has announced the successful completion...